{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:02:52Z","timestamp":1785294172597,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","award":["R01 DK130294"],"award-info":[{"award-number":["R01 DK130294"]}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism","award":["R01 AA028436"],"award-info":[{"award-number":["R01 AA028436"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although liver transplantation (LT) is an effective therapy for cirrhosis, the risk of post-LT NASH is alarmingly high and is associated with accelerated progression to fibrosis\/cirrhosis, cardiovascular disease and decreased survival. Lack of risk stratification strategies hampers early intervention against development of post-LT NASH fibrosis. The liver undergoes significant remodeling during inflammatory injury. During such remodeling, degraded peptide fragments (i.e., \u2018degradome\u2019) of the ECM and other proteins increase in plasma, making it a useful diagnostic\/prognostic tool in chronic liver disease. To investigate whether liver injury caused by post-LT NASH would yield a unique degradome profile that is predictive of severe post-LT NASH fibrosis, a retrospective analysis of 22 biobanked samples from the Starzl Transplantation Institute (12 with post-LT NASH after 5\u00a0years and 10 without) was performed. Total plasma peptides were isolated and analyzed by 1D-LC\u2013MS\/MS analysis using a Proxeon EASY-nLC 1000 UHPLC and nanoelectrospray ionization into an Orbitrap Elite mass spectrometer. Qualitative and quantitative peptide features data were developed from MSn datasets using PEAKS Studio X (v10). LC\u2013MS\/MS yielded\u2009~\u20092700 identifiable peptide features based on the results from Peaks Studio analysis. Several peptides were significantly altered in patients that later developed fibrosis and heatmap analysis of the top 25 most significantly changed peptides, most of which were ECM-derived, clustered the 2 patient groups well. Supervised modeling of the dataset indicated that a fraction of the total peptide signal (~\u200915%) could explain the differences between the groups, indicating a strong potential for representative biomarker selection. A similar degradome profile was observed when the plasma degradome patterns were compared being obesity sensitive (C57Bl6\/J) and insensitive (AJ) mouse strains. The plasma degradome profile of post-LT patients yielded stark difference based on later development of post-LT NASH fibrosis. This approach could yield new \u201cfingerprints\u201d that can serve as minimally-invasive biomarkers of negative outcomes post-LT.<\/jats:p>","DOI":"10.1038\/s41598-023-36867-x","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T10:02:21Z","timestamp":1687255341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The plasma degradome reflects later development of NASH fibrosis after liver transplant"],"prefix":"10.1038","volume":"13","author":[{"given":"Jiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Hern\u00e1ndez-Tejero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane I.","family":"Beier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis V.","family":"Benos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Wilkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Humar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Duarte-Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-5984","authenticated-orcid":false,"given":"Gavin E.","family":"Arteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"36867_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jceh.2019.06.007","volume":"10","author":"F Shirazi","year":"2020","unstructured":"Shirazi, F., Wang, J. & Wong, R. J. Nonalcoholic steatohepatitis becomes the leading indication for liver transplant registrants among US adults born between 1945 and 1965. J. Clin. Exp. Hepatol. 10, 30\u201336. https:\/\/doi.org\/10.1016\/j.jceh.2019.06.007 (2020).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"36867_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/lt.25657","volume":"26","author":"TG Cotter","year":"2020","unstructured":"Cotter, T. G. & Charlton, M. Nonalcoholic steatohepatitis after liver transplantation. Liver Transpl. 26, 141\u2013159. https:\/\/doi.org\/10.1002\/lt.25657 (2020).","journal-title":"Liver Transpl."},{"key":"36867_CR3","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1097\/TP.0000000000002317","volume":"103","author":"P Narayanan","year":"2019","unstructured":"Narayanan, P. et al. Recurrent or de novo allograft steatosis and long-term outcomes after liver transplantation. Transplantation 103, e14\u2013e21. https:\/\/doi.org\/10.1097\/TP.0000000000002317 (2019).","journal-title":"Transplantation"},{"key":"36867_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/tgh.2019.10.12","volume":"5","author":"S Taneja","year":"2020","unstructured":"Taneja, S. & Roy, A. Nonalcoholic steatohepatitis recurrence after liver transplant. Transl. Gastroenterol. Hepatol. 5, 24. https:\/\/doi.org\/10.21037\/tgh.2019.10.12 (2020).","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"36867_CR5","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/lt.23936","volume":"20","author":"M Vallin","year":"2014","unstructured":"Vallin, M. et al. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: Natural history based on liver biopsy analysis. Liver Transpl. 20, 1064\u20131071. https:\/\/doi.org\/10.1002\/lt.23936 (2014).","journal-title":"Liver Transpl."},{"key":"36867_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/17474124.2019.1551132","volume":"13","author":"S Gitto","year":"2019","unstructured":"Gitto, S. et al. Nonalcoholic steatohepatitis before and after liver transplant: Keeping up with the times. Expert Rev. Gastroenterol. Hepatol. 13, 173\u2013178. https:\/\/doi.org\/10.1080\/17474124.2019.1551132 (2019).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"36867_CR7","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1097\/TP.0000000000002916","volume":"103","author":"N Saeed","year":"2019","unstructured":"Saeed, N. et al. Incidence and risks for nonalcoholic fatty liver disease and steatohepatitis post-liver transplant: Systematic review and meta-analysis. Transplantation 103, e345\u2013e354. https:\/\/doi.org\/10.1097\/TP.0000000000002916 (2019).","journal-title":"Transplantation"},{"key":"36867_CR8","doi-asserted-by":"publisher","first-page":"3162670","DOI":"10.1155\/2016\/3162670","volume":"2016","author":"LG Poole","year":"2016","unstructured":"Poole, L. G. & Arteel, G. E. Transitional remodeling of the hepatic extracellular matrix in alcohol-induced liver injury. Biomed. Res. Int. 2016, 3162670. https:\/\/doi.org\/10.1155\/2016\/3162670 (2016).","journal-title":"Biomed. Res. Int."},{"key":"36867_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a005058","author":"P Lu","year":"2011","unstructured":"Lu, P., Takai, K., Weaver, V. M. & Werb, Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb. Perspect. Biol. https:\/\/doi.org\/10.1101\/cshperspect.a005058 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"36867_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","volume":"326","author":"RO Hynes","year":"2009","unstructured":"Hynes, R. O. The extracellular matrix: Not just pretty fibrils. Science 326, 1216\u20131219 (2009).","journal-title":"Science"},{"key":"36867_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1530-0277.1999.tb04201.x","volume":"23","author":"SL Friedman","year":"1999","unstructured":"Friedman, S. L. Stellate cell activation in alcoholic fibrosis\u2014An overview. Alcohol Clin. Exp. Res. 23, 904\u2013910. https:\/\/doi.org\/10.1111\/j.1530-0277.1999.tb04201.x (1999).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"36867_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-5926-6-7","volume":"6","author":"OA Gressner","year":"2007","unstructured":"Gressner, O. A., Weiskirchen, R. & Gressner, A. M. Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp. Hepatol. 6, 7. https:\/\/doi.org\/10.1186\/1476-5926-6-7 (2007).","journal-title":"Comp. Hepatol."},{"key":"36867_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"L Campana","year":"2017","unstructured":"Campana, L. & Iredale, J. P. Regression of liver fibrosis. Semin. Liver Dis. 37, 1\u201310. https:\/\/doi.org\/10.1055\/s-0036-1597816 (2017).","journal-title":"Semin. Liver Dis."},{"key":"36867_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.matbio.2017.11.011","volume":"68\u201369","author":"M Roderfeld","year":"2018","unstructured":"Roderfeld, M. Matrix metalloproteinase functions in hepatic injury and fibrosis. Matrix Biol. 68\u201369, 452\u2013462. https:\/\/doi.org\/10.1016\/j.matbio.2017.11.011 (2018).","journal-title":"Matrix Biol."},{"key":"36867_CR15","doi-asserted-by":"publisher","first-page":"100115","DOI":"10.1016\/j.jhepr.2020.100115","volume":"2","author":"GE Arteel","year":"2020","unstructured":"Arteel, G. E. & Naba, A. The liver matrisome\u2014Looking beyond collagens. JHEP Rep. Innov. Hepatol. 2, 100115. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100115 (2020).","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"36867_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.euprot.2014.02.014","volume":"3","author":"M Schrader","year":"2014","unstructured":"Schrader, M., Schulz-Knappe, P. & Fricker, L. D. Historical perspective of peptidomics. EuPA Open Proteom. 3, 171\u2013182. https:\/\/doi.org\/10.1016\/j.euprot.2014.02.014 (2014).","journal-title":"EuPA Open Proteom."},{"key":"36867_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/bs.enz.2017.08.003","volume":"42","author":"DW Greening","year":"2017","unstructured":"Greening, D. W., Kapp, E. A. & Simpson, R. J. The peptidome comes of age: Mass spectrometry-based characterization of the circulating cancer peptidome. Enzymes 42, 27\u201364. https:\/\/doi.org\/10.1016\/bs.enz.2017.08.003 (2017).","journal-title":"Enzymes"},{"key":"36867_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1515\/hsz-2014-0207","volume":"396","author":"ZW Lai","year":"2015","unstructured":"Lai, Z. W., Petrera, A. & Schilling, O. The emerging role of the peptidome in biomarker discovery and degradome profiling. Biol. Chem. 396, 185\u2013192. https:\/\/doi.org\/10.1515\/hsz-2014-0207 (2015).","journal-title":"Biol. Chem."},{"key":"36867_CR19","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131 (2019).","journal-title":"Nucleic Acids Res."},{"key":"36867_CR20","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605-d612. https:\/\/doi.org\/10.1093\/nar\/gkaa1074 (2021).","journal-title":"Nucleic Acids Res."},{"key":"36867_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","volume":"65","author":"R Pais","year":"2016","unstructured":"Pais, R. et al. NAFLD and liver transplantation: Current burden and expected challenges. J. Hepatol. 65, 1245\u20131257. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.033 (2016).","journal-title":"J. Hepatol."},{"key":"36867_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/TP.0000000000002485","volume":"103","author":"G Germani","year":"2019","unstructured":"Germani, G. et al. Management of recurrent and de novo NAFLD\/NASH after liver transplantation. Transplantation 103, 57\u201367. https:\/\/doi.org\/10.1097\/TP.0000000000002485 (2019).","journal-title":"Transplantation"},{"key":"36867_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cld.2016.12.006","volume":"21","author":"M Kappus","year":"2017","unstructured":"Kappus, M. & Abdelmalek, M. D. Novo and recurrence of nonalcoholic steatohepatitis after liver transplantation. Clin. Liver Dis. 21, 321\u2013335. https:\/\/doi.org\/10.1016\/j.cld.2016.12.006 (2017).","journal-title":"Clin. Liver Dis."},{"key":"36867_CR24","doi-asserted-by":"publisher","first-page":"e1092","DOI":"10.1152\/ajpendo.00583.2005","volume":"291","author":"H Kondo","year":"2006","unstructured":"Kondo, H. et al. Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A\/J vs. obesity-prone C57BL\/6J mice. Am. J. Physiol. Endocrinol. Metab. 291, e1092\u2013e1099. https:\/\/doi.org\/10.1152\/ajpendo.00583.2005 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"36867_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3727\/105221618X15337408678723","volume":"19","author":"AB Rogers","year":"2018","unstructured":"Rogers, A. B. Stress of strains: Inbred mice in liver research. Gene Expr. 19, 61\u201367. https:\/\/doi.org\/10.3727\/105221618X15337408678723 (2018).","journal-title":"Gene Expr."},{"key":"36867_CR26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/pmic.201200493","volume":"13","author":"J Klein","year":"2013","unstructured":"Klein, J. et al. Proteasix: A tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation. Proteomics 13, 1077\u20131082. https:\/\/doi.org\/10.1002\/pmic.201200493 (2013).","journal-title":"Proteomics"},{"key":"36867_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/s-2001-17556","volume":"21","author":"D Schuppan","year":"2001","unstructured":"Schuppan, D., Ruehl, M., Somasundaram, R. & Hahn, E. G. Matrix as a modulator of hepatic fibrogenesis. Semin. Liver Dis. 21, 351\u2013372. https:\/\/doi.org\/10.1055\/s-2001-17556 (2001).","journal-title":"Semin. Liver Dis."},{"key":"36867_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s10620-018-5311-1","volume":"64","author":"KC Lee","year":"2019","unstructured":"Lee, K. C. et al. Dabigatran reduces liver fibrosis in thioacetamide-injured rats. Dig. Dis. Sci. 64, 102\u2013112. https:\/\/doi.org\/10.1007\/s10620-018-5311-1 (2019).","journal-title":"Dig. Dis. Sci."},{"key":"36867_CR29","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/hep.22847","volume":"49","author":"JI Beier","year":"2009","unstructured":"Beier, J. I. et al. Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology 49, 1545\u20131553. https:\/\/doi.org\/10.1002\/hep.22847 (2009).","journal-title":"Hepatology"},{"key":"36867_CR30","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1732467","author":"KJ Kearney","year":"2021","unstructured":"Kearney, K. J., Ari\u00ebns, R. A. S. & Macrae, F. L. The role of fibrin(ogen) in wound healing and infection control. Semin. Thromb. Hemost. https:\/\/doi.org\/10.1055\/s-0041-1732467 (2021).","journal-title":"Semin. Thromb. Hemost."},{"key":"36867_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1055\/s-0036-1579655","volume":"42","author":"AK Kopec","year":"2016","unstructured":"Kopec, A. K. & Luyendyk, J. P. Role of fibrin(ogen) in progression of liver disease: Guilt by association?. Semin. Thromb. Hemost. 42, 397\u2013407. https:\/\/doi.org\/10.1055\/s-0036-1579655 (2016).","journal-title":"Semin. Thromb. Hemost."},{"key":"36867_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32285","author":"SL Friedman","year":"2021","unstructured":"Friedman, S. L. & Pinzani, M. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology https:\/\/doi.org\/10.1002\/hep.32285 (2021).","journal-title":"Hepatology"},{"key":"36867_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells10082024","author":"M Zhang","year":"2021","unstructured":"Zhang, M., Wang, G. & Peng, T. Calpain-mediated mitochondrial damage: An emerging mechanism contributing to cardiac disease. Cells https:\/\/doi.org\/10.3390\/cells10082024 (2021).","journal-title":"Cells"},{"key":"36867_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.RV17008","volume":"25","author":"T Miyazaki","year":"2018","unstructured":"Miyazaki, T. & Miyazaki, A. Dysregulation of calpain proteolytic systems underlies degenerative vascular disorders. J. Atheroscler. Thromb. 25, 1\u201315. https:\/\/doi.org\/10.5551\/jat.RV17008 (2018).","journal-title":"J. Atheroscler. Thromb."},{"key":"36867_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.yjmcc.2020.11.015","volume":"152","author":"W Ge","year":"2021","unstructured":"Ge, W. et al. Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation. J. Mol. Cell Cardiol. 152, 52\u201368. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.11.015 (2021).","journal-title":"J. Mol. Cell Cardiol."},{"key":"36867_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/cvr\/cvs099","volume":"96","author":"E Letavernier","year":"2012","unstructured":"Letavernier, E. et al. The role of calpains in myocardial remodelling and heart failure. Cardiovasc. Res. 96, 38\u201345. https:\/\/doi.org\/10.1093\/cvr\/cvs099 (2012).","journal-title":"Cardiovasc. Res."},{"key":"36867_CR37","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1002\/jcb.29465","volume":"121","author":"R Feng","year":"2020","unstructured":"Feng, R., Du, W., Lui, P., Zhang, J. & Liu, Y. CAPN2 acts as an indicator of hepatitis B virus to induce hepatic fibrosis. J. Cell Biochem. 121, 2428\u20132436. https:\/\/doi.org\/10.1002\/jcb.29465 (2020).","journal-title":"J. Cell Biochem."},{"key":"36867_CR38","doi-asserted-by":"publisher","first-page":"100127","DOI":"10.1016\/j.mbplus.2022.100127","volume":"17","author":"T Sato","year":"2023","unstructured":"Sato, T. et al. Fibrosis resolution in the mouse liver: Role of Mmp12 and potential role of calpain 1\/2. Matrix Biol. Plus 17, 100127. https:\/\/doi.org\/10.1016\/j.mbplus.2022.100127 (2023).","journal-title":"Matrix Biol. Plus"},{"key":"36867_CR39","doi-asserted-by":"publisher","first-page":"e0155163","DOI":"10.1371\/journal.pone.0155163","volume":"11","author":"VH Fengler","year":"2016","unstructured":"Fengler, V. H. et al. Susceptibility of different mouse wild type strains to develop diet-induced NAFLD\/AFLD-associated liver disease. PLoS ONE 11, e0155163. https:\/\/doi.org\/10.1371\/journal.pone.0155163 (2016).","journal-title":"PLoS ONE"},{"key":"36867_CR40","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/oby.2007.238","volume":"15","author":"C Gallou-Kabani","year":"2007","unstructured":"Gallou-Kabani, C. et al. C57BL\/6J and A\/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity 15, 1996\u20132005. https:\/\/doi.org\/10.1038\/oby.2007.238 (2007).","journal-title":"Obesity"},{"key":"36867_CR41","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.2337\/db11-0338","volume":"60","author":"C Poussin","year":"2011","unstructured":"Poussin, C. et al. Oxidative phosphorylation flexibility in the liver of mice resistant to high-fat diet-induced hepatic steatosis. Diabetes 60, 2216\u20132224. https:\/\/doi.org\/10.2337\/db11-0338 (2011).","journal-title":"Diabetes"},{"key":"36867_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.taap.2011.09.019","volume":"257","author":"M Tan","year":"2011","unstructured":"Tan, M. et al. Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice. Toxicol. Appl. Pharmacol. 257, 356\u2013364. https:\/\/doi.org\/10.1016\/j.taap.2011.09.019 (2011).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"36867_CR43","doi-asserted-by":"publisher","first-page":"108399","DOI":"10.1016\/j.jnutbio.2020.108399","volume":"81","author":"RH Isaacson","year":"2020","unstructured":"Isaacson, R. H. et al. Olanzapine-induced liver injury in mice: Aggravation by high-fat diet and protection with sulforaphane. J. Nutr. Biochem. 81, 108399. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108399 (2020).","journal-title":"J. Nutr. Biochem."},{"key":"36867_CR44","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/hep.28918","volume":"65","author":"VL Massey","year":"2017","unstructured":"Massey, V. L. et al. The hepatic \u201cmatrisome\u201d responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice. Hepatology 65, 969\u2013982. https:\/\/doi.org\/10.1002\/hep.28918 (2017).","journal-title":"Hepatology"},{"key":"36867_CR45","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/978-1-4939-7113-8_26","volume":"1627","author":"L Ritti\u00e9","year":"2017","unstructured":"Ritti\u00e9, L. Method for picrosirius red-polarization detection of collagen fibers in tissue sections. Methods Mol. Biol. 1627, 395\u2013407. https:\/\/doi.org\/10.1007\/978-1-4939-7113-8_26 (2017).","journal-title":"Methods Mol. Biol."},{"key":"36867_CR46","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1074\/mcp.M700354-MCP200","volume":"6","author":"H Keshishian","year":"2007","unstructured":"Keshishian, H., Addona, T., Burgess, M., Kuhn, E. & Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 6, 2212\u20132229. https:\/\/doi.org\/10.1074\/mcp.M700354-MCP200 (2007).","journal-title":"Mol. Cell. Proteomics"},{"key":"36867_CR47","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1074\/mcp.M113.036095","volume":"13","author":"SA Carr","year":"2014","unstructured":"Carr, S. A. et al. Targeted peptide measurements in biology and medicine: Best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol. Cell. Proteomics 13, 907\u2013917. https:\/\/doi.org\/10.1074\/mcp.M113.036095 (2014).","journal-title":"Mol. Cell. Proteomics"},{"key":"36867_CR48","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1681\/asn.2019070696","volume":"31","author":"ML Merchant","year":"2020","unstructured":"Merchant, M. L. et al. Proteomic analysis identifies distinct glomerular extracellular matrix in collapsing focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 31, 1883\u20131904. https:\/\/doi.org\/10.1681\/asn.2019070696 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"36867_CR49","doi-asserted-by":"publisher","DOI":"10.1145\/1577069.1755863","author":"H Liu","year":"2009","unstructured":"Liu, H., Lafferty, J. & Wasserman, L. The nonparanormal: Semiparametric estimation of high dimensional undirected graphs. J. Mach. Learn. Res. https:\/\/doi.org\/10.1145\/1577069.1755863 (2009).","journal-title":"J. Mach. Learn. Res."},{"key":"36867_CR50","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/bioinformatics\/bty769","volume":"35","author":"AJ Sedgewick","year":"2019","unstructured":"Sedgewick, A. J. et al. Mixed graphical models for integrative causal analysis with application to chronic lung disease diagnosis and prognosis. Bioinformatics 35, 1204\u20131212. https:\/\/doi.org\/10.1093\/bioinformatics\/bty769 (2019).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36867-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36867-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36867-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T10:11:22Z","timestamp":1687255882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-36867-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["36867"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-36867-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9965"}}